Selective inhibition of human translation termination by a drug-like compound

The drug-like compound PF846 and its derivatives inhibit the translation of specific mRNAs by the human ribosome. Here the authors show how PF846 arrests translation at the stop codon by slowing hydrolysis of the protein nascent chain at the ribosome P-site tRNA by eukaryotic release factor 1 (eRF1)...

Full description

Bibliographic Details
Main Authors: Wenfei Li, Stacey Tsai-Lan Chang, Fred. R. Ward, Jamie H. D. Cate
Format: Article
Language:English
Published: Nature Portfolio 2020-10-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-18765-2
_version_ 1818692113519345664
author Wenfei Li
Stacey Tsai-Lan Chang
Fred. R. Ward
Jamie H. D. Cate
author_facet Wenfei Li
Stacey Tsai-Lan Chang
Fred. R. Ward
Jamie H. D. Cate
author_sort Wenfei Li
collection DOAJ
description The drug-like compound PF846 and its derivatives inhibit the translation of specific mRNAs by the human ribosome. Here the authors show how PF846 arrests translation at the stop codon by slowing hydrolysis of the protein nascent chain at the ribosome P-site tRNA by eukaryotic release factor 1 (eRF1).
first_indexed 2024-12-17T12:52:38Z
format Article
id doaj.art-b86e399a4ec045d89db7d9e3ea9c2b22
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-17T12:52:38Z
publishDate 2020-10-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-b86e399a4ec045d89db7d9e3ea9c2b222022-12-21T21:47:33ZengNature PortfolioNature Communications2041-17232020-10-011111910.1038/s41467-020-18765-2Selective inhibition of human translation termination by a drug-like compoundWenfei Li0Stacey Tsai-Lan Chang1Fred. R. Ward2Jamie H. D. Cate3Department of Molecular & Cell Biology, University of CaliforniaDepartment of Molecular & Cell Biology, University of CaliforniaDepartment of Molecular & Cell Biology, University of CaliforniaDepartment of Molecular & Cell Biology, University of CaliforniaThe drug-like compound PF846 and its derivatives inhibit the translation of specific mRNAs by the human ribosome. Here the authors show how PF846 arrests translation at the stop codon by slowing hydrolysis of the protein nascent chain at the ribosome P-site tRNA by eukaryotic release factor 1 (eRF1).https://doi.org/10.1038/s41467-020-18765-2
spellingShingle Wenfei Li
Stacey Tsai-Lan Chang
Fred. R. Ward
Jamie H. D. Cate
Selective inhibition of human translation termination by a drug-like compound
Nature Communications
title Selective inhibition of human translation termination by a drug-like compound
title_full Selective inhibition of human translation termination by a drug-like compound
title_fullStr Selective inhibition of human translation termination by a drug-like compound
title_full_unstemmed Selective inhibition of human translation termination by a drug-like compound
title_short Selective inhibition of human translation termination by a drug-like compound
title_sort selective inhibition of human translation termination by a drug like compound
url https://doi.org/10.1038/s41467-020-18765-2
work_keys_str_mv AT wenfeili selectiveinhibitionofhumantranslationterminationbyadruglikecompound
AT staceytsailanchang selectiveinhibitionofhumantranslationterminationbyadruglikecompound
AT fredrward selectiveinhibitionofhumantranslationterminationbyadruglikecompound
AT jamiehdcate selectiveinhibitionofhumantranslationterminationbyadruglikecompound